Venture Life Group Retains Paul McGreevy as Board Chair

Venture Life ( (GB:VLG) ) has issued an announcement.

Venture Life Group PLC announced that Mr. Paul McGreevy will remain on the Board as Chair, reversing his earlier decision to step down due to a potential conflict of interest which no longer exists. This decision means the company will not seek a replacement non-executive director, and Mark Adams will continue as a non-executive director and Chair of the Audit Committee. The CEO, Jerry Randall, expressed satisfaction with McGreevy’s continued leadership, highlighting his significant contributions to the company’s development.

More about Venture Life

Venture Life Group PLC is an international consumer self-care company focused on commercializing products for the global self-care market. Headquartered in the UK, the Group’s product portfolio includes products such as Balance Activ for women’s intimate healthcare, Earol® for ENT care, Lift and Glucogel for energy and glucose management, Health and Her for the hormonal lifecycle, and UltraDEX and Dentyl for oral care. These products are primarily available through pharmacies and grocery multiples and are sold in over 90 countries worldwide.

Average Trading Volume: 358,088

Technical Sentiment Signal: Buy

Current Market Cap: £67.87M

For an in-depth examination of VLG stock, go to TipRanks’ Stock Analysis page.